Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.

[1]  Chun-Hsien Yu,et al.  Lack of relationship between beta3-adrenergic receptor gene polymorphism and gestational diabetes mellitus in a Taiwanese population. , 2004, Metabolism: clinical and experimental.

[2]  M. McCarthy,et al.  Insulin resistance and β‐cell dysfunction in normoglycaemic European women with a history of gestational diabetes , 2003, Clinical endocrinology.

[3]  E. Feskens,et al.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies , 2003, Diabetologia.

[4]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[5]  A. Hattersley,et al.  Increased risk of diabetes in first-degree relatives of young-onset type 2 diabetic patients compared with relatives of those diagnosed later. , 2002, Diabetes care.

[6]  J. Friedman,et al.  Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. , 2002, American journal of physiology. Endocrinology and metabolism.

[7]  D. Corella,et al.  Gender specific associations of the Trp64Arg mutation in the β3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation , 2001 .

[8]  K. Silver,et al.  Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. , 2001, Journal of molecular endocrinology.

[9]  M. Alevizaki,et al.  Study of the Trp64Arg polymorphism of the beta3-adrenergic receptor in Greek women with gestational diabetes. , 2000, Diabetes care.

[10]  T. Buchanan,et al.  Gestational diabetes: risk or myth? , 1999, The Journal of clinical endocrinology and metabolism.

[11]  S. Haffner,et al.  Trp64Arg Polymorphism of theβ 3-Adrenergic Receptor Gene in Pregnancy: Association with Mild Gestational Diabetes Mellitus , 1999 .

[12]  M. Kanamori,et al.  Polymorphism of the beta3-adrenergic receptor gene and weight gain in pregnant diabetic women. , 1999, Diabetes research and clinical practice.

[13]  S. Amini,et al.  Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. , 1999, American journal of obstetrics and gynecology.

[14]  N. Fineberg,et al.  Gestational Diabetes: Should It Be Added to the Syndrome of Insulin Resistance? , 1997, Diabetes Care.

[15]  F. Lönnqvist,et al.  Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. , 1996, Diabetologia.

[16]  R. DeFronzo,et al.  Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: Same disease, another name? , 1995 .

[17]  C. Bogardus,et al.  Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. , 1995, The New England journal of medicine.

[18]  L. Groop,et al.  Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. , 1995, The New England journal of medicine.

[19]  E. Bonifacio,et al.  Disease Sensitivity and Specificity of 52 Assays for Glutamic Acid Decarboxylase Antibodies: The Second International GADAB Workshop , 1995, Diabetes.

[20]  M. McCarthy,et al.  Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease , 1995, Diabetologia.

[21]  T. Hansen,et al.  Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus , 1993, The Lancet.

[22]  Y. Ebina,et al.  Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. , 1993, Biochemical and biophysical research communications.

[23]  C. Kühl.  Insulin Secretion and Insulin Resistance in Pregnancy and GDM: Implications for Diagnosis and Management , 1991, Diabetes.

[24]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[25]  E. Bonifacio,et al.  Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays , 1990, Diabetologia.

[26]  L. Jovanovič,et al.  Screening for Gestational Diabetes: Optimum Timing and Criteria for Retesting , 1985, Diabetes.

[27]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[28]  A. Huggett,et al.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. , 1957, Lancet.

[29]  A. Strosberg,et al.  The human β3-adrenoceptor: the search for a physiological function , 1994 .